Document Detail

Medical devices; establishment registration and device listing for manufacturers and distributors of devices; companion to direct final rule--FDA. Proposed rule.
MedLine Citation:
PMID:  10185813     Owner:  NLM     Status:  MEDLINE    
The Food and Drug Administration (FDA) is proposing to amend certain regulations governing establishment registration and device listing by domestic distributors. This proposed rule is a companion document to the direct final rule published elsewhere in this issue of the Federal Register. These amendments are being made to implement revisions to the Federal Food, Drug, and Cosmetic Act (the act) as amended by the Food and Drug Administration Modernization Act of 1997 (FDAMA). This companion proposed rule is being issued under FDAMA and the act as amended.
Related Documents :
12059493 - Differential sum rule for the relaxation rate in the cuprates.
8517193 - Do tobacco companies avoid proper use of warnings in magazine ads?
16188423 - The relationship between manic symptoms on the dash ii and ymrs and feeding/mealtime be...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Federal register     Volume:  63     ISSN:  0097-6326     ISO Abbreviation:  Fed Regist     Publication Date:  1998 Sep 
Date Detail:
Created Date:  1998-12-15     Completed Date:  1998-12-15     Revised Date:  2000-12-18    
Medline Journal Info:
Nlm Unique ID:  7808722     Medline TA:  Fed Regist     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  51874-5     Citation Subset:  H    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Device Approval / legislation & jurisprudence*
Industry / legislation & jurisprudence*
United States
United States Food and Drug Administration

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Medical devices; establishment registration and device listing for manufacturers and distributors of...
Next Document:  Guidance for industry: donor screening for antibodies to HTLV-II; availability--FDA. Notice.